Concepedia

Katsuyo Ohashi

KO

Statistics

Publications

9

Citations

327

H-Index

9

Active since

2000

Affiliations

Pfizer (Japan)(Current)

Pfizer (United States)

Tohoku University

Katsuyo Ohashi is an author at Pfizer (Japan) specializing in neuropharmacology, pharmacology, and medicine.

Publications per year

2000–2010

9

Publications

9

Exploring the Structural Basis of Neurotoxicity in C<sub>17</sub>-Polyacetylenes Isolated from Water Hemlock

Koji Uwai, Katsuyo Ohashi, Yoshiaki Takaya et al. · Journal of Medicinal Chemistry · 2000 · 75 citations

, , +12

Pharmacological Evaluation of a Novel Cannabinoid 2 (CB2) Ligand, PF-03550096, In Vitro and In Vivo by Using a Rat Model of Visceral Hypersensitivity

Akira Kikuchi, Katsuyo Ohashi, Yutaka Sugie et al. · Journal of Pharmacological Sciences · 2008 · 66 citations · Full text

, , +11

Novel Non-Peptide Nociceptin/Orphanin FQ Receptor Agonist, 1-[1-(1-Methylcyclooctyl)-4-piperidinyl]-2-[(3<i>R</i>)-3-piperidinyl]-1<i>H</i>-benzimidazole: Design, Synthesis, and Structure−Activity Relationship of Oral Receptor Occupancy in the Brain for Orally Potent Antianxiety Drug

Shigeo Hayashi, Akiko Hirao, Aki Imai et al. · Journal of Medicinal Chemistry · 2009 · 46 citations · Full text

, , +16

Abolishment of TNBS-induced visceral hypersensitivity in mast cell deficient rats

Katsuyo Ohashi, Yasushi Sato, Mitsuhisa Kawai et al. · Life Sciences · 2008 · 30 citations

, , +10

Colonic Mast Cell Infiltration in Rats with TNBS-Induced Visceral Hypersensitivity

Katsuyo Ohashi, Yasushi Sato, Hiroshi Iwata et al. · Journal of Veterinary Medical Science · 2007 · 26 citations · Full text

, , +17

1–5 of 9